CONSUN PHARMA (01681): Lee Cheuk Kwong appointed as Independent Non-executive Director.
Kangzin Pharmaceutical (01681) announced that, effective from February 24, 2025, Ms. Chen Yujun has resigned as an independent...
CONSUN PHARMA (01681) announced that, effective from February 24, 2025: Ms. Chen Yujun has resigned as an independent non-executive director and will no longer serve as chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Li Zhuoguang has been appointed as an independent non-executive director, chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Fang Peicheng will no longer concurrently serve as the Chief Financial Officer; Ms. Chen Yujun has been appointed as the Chief Financial Officer.
Related Articles
Citi Raises 3M (MMM.US) Price Target to $188; New Businesses Such as Data Centers Support Long-Term Growth
HK Stock Market Move | ASCLETIS-B (01672) rises nearly 9% intraday; once-weekly oral peptide pipeline for obesity treatment achieves positive preclinical data.
HK Stock Market Move | The three major telecom operators collectively declined; China Mobile Limited (00941) saw both revenue and net profit fall in Q3, with industry revenue under pressure reflecting a VAT-driven reset.
Citi Raises 3M (MMM.US) Price Target to $188; New Businesses Such as Data Centers Support Long-Term Growth
HK Stock Market Move | ASCLETIS-B (01672) rises nearly 9% intraday; once-weekly oral peptide pipeline for obesity treatment achieves positive preclinical data.
HK Stock Market Move | The three major telecom operators collectively declined; China Mobile Limited (00941) saw both revenue and net profit fall in Q3, with industry revenue under pressure reflecting a VAT-driven reset.
